Ying Shang

2.5k total citations · 2 hit papers
83 papers, 1.2k citations indexed

About

Ying Shang is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ying Shang has authored 83 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Epidemiology, 17 papers in Hepatology and 15 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ying Shang's work include Liver Disease Diagnosis and Treatment (22 papers), Liver Disease and Transplantation (14 papers) and Pneumonia and Respiratory Infections (12 papers). Ying Shang is often cited by papers focused on Liver Disease Diagnosis and Treatment (22 papers), Liver Disease and Transplantation (14 papers) and Pneumonia and Respiratory Infections (12 papers). Ying Shang collaborates with scholars based in Sweden, China and United States. Ying Shang's co-authors include Hannes Hagström, Weili Xu, Anna Marseglia, Laura Fratiglioni, Linnea Widman, Patrik Nasr, Abigail Dove, Giulia Grande, Erika J. Laukka and Axel Wester and has published in prestigious journals such as PLoS ONE, Hepatology and Neurology.

In The Last Decade

Ying Shang

73 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Natural history and progression of metabolic dysfunction-associated steatotic liver disease

2024 93 citations Hannes Hagström, Ying Shang et al. profile →
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes

2024 36 citations Axel Wester, Ying Shang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ying Shang Sweden	21	578	267	265	158	156	83	1.2k
Sharon Torres United States	6	320 0.6×	358 1.3×	244 0.9×	30 0.2×	103 0.7×	8	1.1k
Julie Fitzpatrick United Kingdom	20	498 0.9×	133 0.5×	479 1.8×	40 0.3×	197 1.3×	52	1.6k
Maria F. Vasiloglou Switzerland	18	247 0.4×	136 0.5×	652 2.5×	173 1.1×	35 0.2×	35	1.4k
Marisa Chiloiro Italy	20	297 0.5×	193 0.7×	263 1.0×	39 0.2×	88 0.6×	38	1.2k
Hiroki Fujii Japan	21	138 0.2×	325 1.2×	286 1.1×	40 0.3×	34 0.2×	56	1.2k
Gregory S. Sayuk United States	30	297 0.5×	155 0.6×	282 1.1×	189 1.2×	52 0.3×	128	2.4k
O.F.W. James United Kingdom	20	736 1.3×	149 0.6×	162 0.6×	76 0.5×	483 3.1×	49	1.5k
Constantinos Koshiaris United Kingdom	17	240 0.4×	182 0.7×	212 0.8×	69 0.4×	33 0.2×	56	1.7k
P J J Sauer Netherlands	27	250 0.4×	123 0.5×	277 1.0×	60 0.4×	144 0.9×	66	1.7k
Anastasia Thanopoulou Greece	17	155 0.3×	476 1.8×	406 1.5×	66 0.4×	29 0.2×	38	1.3k

Countries citing papers authored by Ying Shang

Since Specialization

Citations

This map shows the geographic impact of Ying Shang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Shang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Shang more than expected).

Fields of papers citing papers by Ying Shang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Shang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Shang. The network helps show where Ying Shang may publish in the future.

Co-authorship network of co-authors of Ying Shang

This figure shows the co-authorship network connecting the top 25 collaborators of Ying Shang. A scholar is included among the top collaborators of Ying Shang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Shang. Ying Shang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boeckmans, Joost, et al.. (2025). Temporal comorbidity patterns preceding MASLD-related major adverse liver outcomes: a nationwide population-based case–control study in Sweden. BMJ Public Health. 3(2). e003322–e003322.

Vaz, Juan, Patrik Nasr, Anders Helander, et al.. (2025). Phosphatidylethanol levels distinguish steatotic liver disease subgroups and are associated with risk of major liver outcomes. Journal of Hepatology. 83(5). 1011–1022. 7 indexed citations

Wang, Qingwang, et al.. (2025). Progress and Perspectives on UAV Visual Object Tracking. IEEE Journal of Selected Topics in Applied Earth Observations and Remote Sensing. 18. 20214–20239.

Zhang, Yun, Yi-Bing Zhang, Weiguo Hu, et al.. (2024). Development of an automated processing platform based on luciferase fused TPP17 to detect specific Treponema pallidum antibody in clinical serum with high sensitivity and rapidity. International Journal of Biological Macromolecules. 283(Pt 1). 137530–137530. 1 indexed citations

Yang, Wen, Fahim Ebrahimi, Stefano Romeo, et al.. (2024). Risk of major adverse liver outcomes among first‐degree relatives of individuals with MASLD. Liver International. 44(5). 1253–1264. 2 indexed citations

Widman, Linnea, et al.. (2024). Timely Follow‐Up After a First Diagnosis of Cirrhosis is Associated With Reduced Mortality but No Impact on Rehospitalisations: A Population‐Based Cohort of 8852 Patients. Alimentary Pharmacology & Therapeutics. 61(1). 109–121. 1 indexed citations

Nasr, Patrik, Ying Shang, Axel Wester, et al.. (2024). Socioeconomic factors associated with the presence of and outcomes in metabolic dysfunction‐associated steatotic liver disease. Liver International. 44(11). 3050–3059. 6 indexed citations

Shang, Ying, Lili Zhao, Zhengwu Yang, et al.. (2023). Relationship between clinical features and droplet digital PCR copy number in non-HIV patients with pneumocystis pneumonia. BMC Infectious Diseases. 23(1). 833–833. 5 indexed citations

Ebrahimi, Fahim, Hannes Hagström, Jiangwei Sun, et al.. (2023). Familial coaggregation of MASLD with hepatocellular carcinoma and adverse liver outcomes: Nationwide multigenerational cohort study. Journal of Hepatology. 79(6). 1374–1384. 35 indexed citations

10.

Stål, Per, Patrik Nasr, Mattias Ekstedt, et al.. (2023). Long-term major adverse liver outcomes in 1,260 patients with non-cirrhotic NAFLD. JHEP Reports. 6(2). 100915–100915. 16 indexed citations

11.

Shang, Ying, Qing Shen, Elliot B. Tapper, Axel Wester, & Hannes Hagström. (2023). Risk of injuries before and after a diagnosis of cirrhosis: A population-based cohort study. Hepatology Communications. 7(11). 3 indexed citations

12.

Guo, Jie, Abigail Dove, Ying Shang, et al.. (2023). Associations Between Mid- to Late-Life Body Mass Index and Chronic Disease-Free Survival: A Nationwide Twin Study. The Journals of Gerontology Series A. 79(1). 2 indexed citations

13.

Shang, Ying, Linnea Widman, Fahim Ebrahimi, et al.. (2023). Risk of infections in non‐alcoholic fatty liver disease: A nationwide population‐based cohort study. Liver International. 43(10). 2142–2152. 11 indexed citations

14.

Shang, Ying & Hannes Hagström. (2022). Statins Are Underused in Women With NAFLD After Cardiovascular Events Compared With Matched Control Subjects. Clinical Gastroenterology and Hepatology. 21(5). 1359–1361.e2. 8 indexed citations

15.

Wang, Rui, Chengxuan Qiu, Christina S. Dintica, et al.. (2021). Shared risk and protective factors between Alzheimer's disease and ischemic stroke: A population‐based longitudinal study. Alzheimer s & Dementia. 17(2). 191–204. 11 indexed citations

16.

Wu, Wei, Weili Xu, Simon Englund, et al.. (2020). Can health behaviours prolong survival and compress the period of survival with the disability? A population-based cohort study. Age and Ageing. 50(2). 480–487. 6 indexed citations

17.

Cao, Zhi, Christina S. Dintica, Ying Shang, et al.. (2020). The Role of Cognitive Impairment, Physical Disability, and Chronic Conditions in the Association of Sleep Duration With All-Cause Mortality Among Very Old Adults. Journal of the American Medical Directors Association. 21(10). 1458–1463.e2. 15 indexed citations

18.

Shang, Ying, Patrik Nasr, Mattias Ekstedt, et al.. (2020). Non-alcoholic fatty liver disease does not increase dementia risk although histology data might improve risk prediction. JHEP Reports. 3(2). 100218–100218. 33 indexed citations

19.

Pu, Ning, Yali Zheng, Donghong Yang, et al.. (2018). Admission Pentraxin‐3 Level Predicts Severity of Community‐Acquired Pneumonia Independently of Etiology. PROTEOMICS - CLINICAL APPLICATIONS. 13(4). e1800117–e1800117. 9 indexed citations

20.

Wu, Peng, et al.. (2016). Rannasangpei Is a Therapeutic Agent in the Treatment of Vascular Dementia. Evidence-based Complementary and Alternative Medicine. 2016(1). 2530105–2530105. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact